NFE2L2 and lung adenocarcinoma: Two subtypes of KEAP1/NFE2L2-mutant lung adenocarcinoma were identified based on both patient and cell line samples, and genomic and clinicopathological features of KEAP1/NFE2L2 mutations were characterized.